Russell Investments Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-95,822
| Closed | -$178K | – | 3220 |
|
2023
Q3 | $178K | Buy |
95,822
+17,689
| +23% | +$32.9K | ﹤0.01% | 2512 |
|
2023
Q2 | $215K | Buy |
78,133
+19,099
| +32% | +$52.5K | ﹤0.01% | 2459 |
|
2023
Q1 | $185K | Buy |
59,034
+13,798
| +31% | +$43.3K | ﹤0.01% | 2491 |
|
2022
Q4 | $267K | Buy |
45,236
+7,243
| +19% | +$42.7K | ﹤0.01% | 2494 |
|
2022
Q3 | $332K | Sell |
37,993
-648
| -2% | -$5.66K | ﹤0.01% | 2393 |
|
2022
Q2 | $290K | Buy |
+38,641
| New | +$290K | ﹤0.01% | 2448 |
|
2021
Q4 | – | Sell |
-5,056
| Closed | -$225K | – | 3002 |
|
2021
Q3 | $225K | Buy |
5,056
+4,494
| +800% | +$200K | ﹤0.01% | 2742 |
|
2021
Q2 | $21K | Buy |
+562
| New | +$21K | ﹤0.01% | 3175 |
|